Senseonics (NYSE:SENS) Shares Gap Up - Here's Why

Shares of Senseonics Holdings, Inc. (NYSE:SENS - Get Free Report) gapped up before the market opened on Thursday . The stock had previously closed at $1.17, but opened at $1.23. Senseonics shares last traded at $1.29, with a volume of 5,848,861 shares.

Analyst Ratings Changes

Several equities research analysts have commented on SENS shares. HC Wainwright restated a "buy" rating and set a $2.00 price target on shares of Senseonics in a research note on Friday, November 15th. StockNews.com began coverage on Senseonics in a research note on Thursday, December 26th. They issued a "sell" rating for the company.

Senseonics Stock Performance

The company has a debt-to-equity ratio of 59.17, a quick ratio of 2.38 and a current ratio of 2.47. The firm has a market capitalization of $738.21 million, a price-to-earnings ratio of -9.54 and a beta of 0.69. The stock's fifty day moving average is $0.73 and its two-hundred day moving average is $0.48.

Insider Activity at Senseonics

In related news, CEO Timothy T. Goodnow acquired 315,000 shares of the firm's stock in a transaction on Tuesday, December 10th. The stock was bought at an average cost of $0.31 per share, with a total value of $97,650.00. Following the acquisition, the chief executive officer now directly owns 11,310,355 shares in the company, valued at approximately $3,506,210.05. The trade was a 2.86 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Frederick T. Sullivan bought 124,933 shares of the business's stock in a transaction dated Thursday, December 12th. The stock was bought at an average price of $0.38 per share, for a total transaction of $47,474.54. Following the purchase, the chief financial officer now owns 2,478,844 shares in the company, valued at approximately $941,960.72. This represents a 5.31 % increase in their position. The disclosure for this purchase can be found here. 3.60% of the stock is currently owned by company insiders.

Remove Ads

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the company. Raymond James Financial Inc. bought a new position in Senseonics during the fourth quarter worth $26,000. HighTower Advisors LLC bought a new position in shares of Senseonics in the 4th quarter worth about $32,000. FMR LLC boosted its holdings in shares of Senseonics by 48,267.2% in the 3rd quarter. FMR LLC now owns 168,318 shares of the company's stock valued at $59,000 after buying an additional 167,970 shares during the period. Ridgecrest Wealth Partners LLC acquired a new stake in Senseonics during the fourth quarter worth about $60,000. Finally, Beck Mack & Oliver LLC bought a new position in Senseonics in the fourth quarter worth about $79,000. Institutional investors and hedge funds own 12.36% of the company's stock.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.